Smiths Medical Issues Recall On Tracheostomy Kits Due To Defect Linked Over 30 Injuries

Smith's medical recalls airway tubes; the kit used for supporting breathing when the airway is blocked, resulted in injuries to patients. Therefore, the manufacturing defects were the cause of the withdrawal of the kits. These defects could cause the pilot balloon to detach from the inflation line and result in inadequate ventilation to the patients. So far this has been Smith's latest recall. Smiths approached consumers to discard the affected products and approach representatives for device replacement.

 In May the company also recalled Bivona, a type of tracheostomy tube, due to manufacturing defects. The recall was in context of 35 injuries and 1 death. According to FDA database entries posted on Wednesday, the recall includes the Portex Bluselect, Blue Griggs and Bluperc kits, comprising more than 850,000 units. Related to this particular issue, Smiths received more than 10 complaints regarding serious injuries to the patients.

The FDA also issued a second recall which was associated with the problem involved in the ParaPac ventilator kits. More than 12,000 devices were impacted by an issue with the knob controlling air delivery, which could shift from its original setting when adjusted to extreme levels. This year, Smiths Medical has faced multiple recalls flagged by the FDA due to potential risks of severe injury or death. In fact, the company has encountered several recalls over the past three years, including receiving a formal warning letter.

 In 2022, ICU Medical, acquired Smith’s for 2.35 billion dollars affiliated to production of airway management devices and infusion pumps.ICU Medical CEO Vivek Jain recently reported to investors that the ongoing safety and quality issues acquisition has been “more challenging than we had expected”.